VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BIO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
BIOBio-Rad Laboratories, Inc.
$295.30$8.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksBIOQuarterly Cash Flow

Bio-Rad Laboratories, Inc. (BIO) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Bio-Rad Laboratories, Inc. (BIO) quarterly cash flow statement — complete operating, investing & financing history

BIO Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Cash from Operations108.1M164.9M120.9M116.5M129.9M124.15M163.61M97.65M69.79M81.05M97.71M98.07M98.12M90.42M11.03M53.27M50.49M157.92M230.36M154.62M
Operating CF Margin %18.26%23.79%18.51%17.88%22.19%18.6%25.18%15.29%11.43%11.9%15.46%14.4%14.5%12.38%1.62%7.71%7.21%21.55%30.84%21.6%
Operating CF Growth %-16.78%32.82%-26.1%19.31%86.12%53.19%67.44%-0.43%-28.87%-10.37%786.11%84.1%94.32%-42.74%-95.21%-65.55%-55.55%-44.54%69.8%67.85%
Net Income-11M720M-341.9M-120.1M64M-715.8M653.2M-2.17B383.9M349.7M106.3M-1.16B69M833.5M-162.8M-925.2M-3.37B-1.57B3.93B914.1M
Depreciation & Amortization052.4M54.2M-38.1M38.1M49.3M38.9M36.4M37.1M37.2M37.3M35.8M35.6M40M34.3M34.1M33.4M33.7M33.7M33.7M
Stock-Based Compensation000-15.3M15.3M16.4M15.6M15M15.3M16.2M15.9M12.6M16.6M18.1M15.7M13.6M13.5M15M13.1M11.4M
Deferred Taxes0190.2M-88.4M00000000000000000
Other Non-Cash Items119.1M-1.06B511.4M333.6M-31.1M717.3M-764.79M2.89B-420.51M-313.85M-59.29M1.59B17.22M-949.88M296.23M1.34B4.55B2.16B-4.87B-1.03B
Working Capital Changes0260.7M-14.4M-43.6M43.6M56.95M220.7M-679.5M54M-8.2M-2.5M-381.8M-40.3M148.7M-172.4M-409.8M-1.17B-475.8M1.12B226.7M
Change in Receivables03.9M4.2M-37.2M37.2M-9.4M-7.4M-4.4M37.4M-20.2M26.4M6.6M-1.4M-42.9M1.3M1M-46.8M-9.6M-23.4M11.6M
Change in Inventory051.6M13.6M17.9M-17.9M24.5M15.2M-22.4M-8.8M15.4M-6.4M-25.2M-30.1M-8.2M-48.3M-66.8M-35.5M17.9M13.9M8.5M
Change in Payables0-1.3M-33.3M-29.8M29.8M-16.5M2.2M17.8M-44.4M20.6M-37.7M-42.9M8.2M-24.5M-26.6M-4.2M-38.9M47.5M56.6M10.3M
Cash from Investing-93.2M-34.2M-43M-115.4M2.9M-30.54M-55.64M-30.93M-43.09M72.2M-9.5M27.98M-70.47M-69.31M-88.42M-144.48M-916.14M-554.48M-81.35M-100.28M
Capital Expenditures-30M-45.8M-31.7M-45.7M-34.4M-42.91M-40.23M-42.28M-40.18M-42.24M-44.07M-34.64M-35.73M-45.56M-27.57M-17.33M-33.08M-43.24M-34.63M-23.39M
CapEx % of Revenue5.07%6.61%4.85%7.01%5.88%6.43%6.19%6.62%6.58%6.2%6.97%5.09%5.28%6.24%4.05%2.51%4.72%5.9%4.64%3.27%
Acquisitions00-1.8M-216.6M000002.5M0000-100.75M00-125.52M00
Investments--------------------
Other Investing100K793.6M000-39K-23.35M66K26K107K65K39K0-1.33M6K1.47M0039K1K
Cash from Financing-44M3.3M-52.5M-136.3M-97.7M-26.25M-95.99M-96.59M21K-200.62M-26.6M-202.74M4.31M-86.62M-8.77M-121.33M1.19B4.63M-15.58M2.87M
Debt Issued (Net)0-200K-300K-200K-100K-41K-123K-118K-118K-118K-118K-116K-115K-143K-113K-150K1.19B-1.38M-122K-122K
Equity Issued (Net)03.9M-50M-136M-101.9M-14K-97.84M-101M-4.75M-200M-21.32M-207.41M0-90.68M0-125M0000
Dividends Paid-33.3M0000000000000000000
Share Repurchases-47.8M0-53.4M-140.2M-101.9M-14K-97.84M-101M-4.75M-200M-21.32M-207.41M0-90.68M0-125M0000
Other Financing-10.7M-400K-2.2M-100K4.3M-26.19M1.97M4.53M4.89M-502K-5.16M4.79M4.42M4.2M-8.66M3.82M4.18M6.01M-15.46M2.99M
Net Change in Cash-23.2M132M26.5M-151.4M33.3M77.61M4.47M-26.04M29.38M-53.95M67.83M-74.02M29.96M-83.7M-78.66M-205.75M331.52M-393.39M127.36M59.46M
Free Cash Flow78.1M119.1M89.2M70.8M95.5M81.25M99.97M55.37M29.62M38.8M53.64M63.43M62.39M43.49M-16.55M35.94M17.42M114.68M195.74M131.24M
FCF Margin %13.19%17.18%13.66%10.87%16.31%12.17%15.39%8.67%4.85%5.7%8.49%9.31%9.22%5.95%-2.43%5.2%2.49%15.65%26.2%18.33%
FCF Growth %-18.22%46.59%-10.77%27.88%222.46%109.39%86.37%-12.71%-52.53%-10.77%424.15%76.5%258.26%-62.08%-108.45%-72.62%-81.48%-53.3%69.2%77.33%
FCF per Share2.904.413.312.603.422.903.571.951.041.351.842.162.101.46-0.561.210.583.836.484.35
FCF Conversion (FCF/Net Income)-0.21x0.23x-0.35x0.37x2.03x-0.17x0.25x-0.05x0.18x0.23x0.92x-0.08x1.42x0.11x-0.07x-0.06x-0.01x-0.10x0.06x0.17x
Interest Paid00000000000000000000
Taxes Paid00000000000000000000